Products for Research Use Only
RegisterLogin

Apatinib-d8 (free base)

CAT: 0804-HY-13342ASSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13342ASSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Apatinib-d8 (free base) is the deuterium labeled Apatinib free base[1]. Apatinib free base (YN968D1 free base) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 (IC50=1 nM) . Apatinib free base (YN968D1 free base) is an anti-angiogenic drug for the research of advanced or metastatic gastric cancer. Apatinib free base (YN968D1 free base) potently inhibits Ret, c-Kit and c-Src with IC50s of 13, 429 and 530 nM, respectively. It also inhibits cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ[2][3][4].
CAS Number
2468771-43-7
Product Name Alternative
YN968D1-d8 (free base)
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Autophagy; c-Kit; RET; Src; VEGFR
Type
Isotope-Labeled Compounds
Related Pathways
Autophagy; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
92.56
Solubility
DMSO : 30 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=CC=CN=C1NCC2=CC=NC=C2)NC3=CC=C(C4(C#N)C([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H])C=C3
Molecular Formula
C24H15D8N5O
Molecular Weight
405.52
Precautions
H315, H319, H335
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Roviello G, et al. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. Cancer Lett. 2016 Mar 28;372 (2) :187-91.|[3]Scott LJ. Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers. Drugs. 2018 May;78 (7) :747-758. doi: 10.1007/s40265-018-0903-9.|[4]Tian S, et al. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo. Cancer Sci. 2011 Jul;102 (7) :1374-80.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-13342SApatinib-d8 (hydrochloride)
HY-142440S-01Apatinib 25-N-oxide-d8 (dihydrochloride)
HY-13342Apatinib
HY-109118Masupirdine (free base)
HY-152852-01Mefatinib (free base)
HY-19651-01Zanapezil (free base)
HY-116031ATC0175 (free base)
HY-120421SW116 (free base)
HY-139806SRA880 (free base)
HY-100444-01SIS3 (free base)

Alternative Products

CatalogName
B1613-25Apatinib (Free base)
123316Apatinib free base
TB0954TMB free base
A8893-10Rucaparib (free base)
FX56092-01Xylazine - free base
T-8100-01Tryptamine, free base
XN175452-01Norharman - free base
MBS5779607Amidantel free base
533249ML355 free base
414310Neamine Free Base

Popular Products